RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Product enhancement of small and large molecules in a range of dosage forms
Proprietary supercritical fluid (SCF) technology to improve bioavailability, enhance stability and optimise drug delivery for small and large molecules in a range of dosage forms. More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
The National Institute of Allergy and Infectious Diseases – Developmental Therapeutics Review – Q4 2010
Nov 2010 - 40 pages - $500
Urinary Tract Infections (UTI) - Pipeline Assessment and Market Forecasts to 2017
Dec 2010 - 40 pages - $2,000
Urinary Tract Infections Therapy Area Pipeline Report
Nov 2010 - 178 pages - $1,495
Urinary Tract Cancer - Pipeline Review, Q3 2011
Jul 2011 - 296 pages - $500
Urinary Tract Cancer - Pipeline Review, Q1 2011
Jan 2011 - 23 pages - $500
Infectious Diseases Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Adenovirus Infection Global Clinical Trials Review, Q2, 2011
May 2011 - 32 pages - $1,000
Stakeholder Opinions: Urinary Tract Infections Growing resistance rates bring opportunities for both new and old drugs
Apr 2009 - 126 pages - $3,800
Urinary Tract Infections - Pipeline Review, Q1 2011
Feb 2011 - 39 pages - $500
Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
Oct 2009 - 17 pages - $500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Infectious diseases del
Diseases del
Urinary tract infection del
Development phase
Phase II del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us